skip to main content
Idioma:
Resultados 1 2 3 4 5 next page
Refinado por: tipo de recurso: Newsletter Articles remover
Result Number Material Type Add to My Shelf Action Record Details and Options
1
Vanda Pharmaceuticals Inc.; Vanda Pharmaceuticals, Northwell Health Conduct ODYSSEY Trial In Patients With Severe COVID-19 Pneumonia
Vanda Pharmaceuticals Inc.; Vanda Pharmaceuticals, Northwell Health Conduct ODYSSEY Trial In Patients With Severe COVID-19 Pneumonia
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

Vanda Pharmaceuticals Inc.; Vanda Pharmaceuticals, Northwell Health Conduct ODYSSEY Trial In Patients With Severe COVID-19 Pneumonia

Respiratory Therapeutics Week, 2020, p.1739

Atlanta: NewsRx

Texto completo disponível

Citações Citado por
2
Vanda Pharmaceuticals, Northwell Health Conduct ODYSSEY Trial In Patients With Severe COVID-19 Pneumonia
Vanda Pharmaceuticals, Northwell Health Conduct ODYSSEY Trial In Patients With Severe COVID-19 Pneumonia
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

Vanda Pharmaceuticals, Northwell Health Conduct ODYSSEY Trial In Patients With Severe COVID-19 Pneumonia

Biotech Week, 2020, p.1739

NewsRX LLC

Texto completo disponível

Citações Citado por
3
Vanda Pharmaceuticals Inc.; Patent Issued for Method Of Predicting A Predisposition To QT Prolongation (USPTO 10,563,261)
Vanda Pharmaceuticals Inc.; Patent Issued for Method Of Predicting A Predisposition To QT Prolongation (USPTO 10,563,261)
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

Vanda Pharmaceuticals Inc.; Patent Issued for Method Of Predicting A Predisposition To QT Prolongation (USPTO 10,563,261)

Drug Week, 2020, p.815

Atlanta: NewsRx

Texto completo disponível

Citações Citado por
4
Skin Diseases and Conditions - Atopic Dermatitis; Researchers from Vanda Pharmaceuticals Inc. Report New Studies and Findings in the Area of Atopic Dermatitis (Y Correlation of Age-of-onset of Atopic Dermatitis With Filaggrin Loss-of-function Variant Status)
Skin Diseases and Conditions - Atopic Dermatitis; Researchers from Vanda Pharmaceuticals Inc. Report New Studies and Findings in the Area of Atopic Dermatitis (Y Correlation of Age-of-onset of Atopic Dermatitis With Filaggrin Loss-of-function Variant Status)
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

Skin Diseases and Conditions - Atopic Dermatitis; Researchers from Vanda Pharmaceuticals Inc. Report New Studies and Findings in the Area of Atopic Dermatitis (Y Correlation of Age-of-onset of Atopic Dermatitis With Filaggrin Loss-of-function Variant Status)

Biotech Business Week, 2020, p.280

Atlanta: NewsRx

Texto completo disponível

Citações Citado por
5
Vanda Pharmaceuticals, Inc.; Patent Issued for Method of Predicting a Predisposition to QT Prolongation
Vanda Pharmaceuticals, Inc.; Patent Issued for Method of Predicting a Predisposition to QT Prolongation
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

Vanda Pharmaceuticals, Inc.; Patent Issued for Method of Predicting a Predisposition to QT Prolongation

Biotech Business Week, 2015, p.141

Atlanta: NewsRx

Texto completo disponível

Citações Citado por
6
New Findings in Polar Research Described from Natural History Museum (Characterisation of a deep-water moss from the perennially ice-covered Lake Vanda, Antarctica)
New Findings in Polar Research Described from Natural History Museum (Characterisation of a deep-water moss from the perennially ice-covered Lake Vanda, Antarctica)
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

New Findings in Polar Research Described from Natural History Museum (Characterisation of a deep-water moss from the perennially ice-covered Lake Vanda, Antarctica)

Ecology, Environment & Conservation, 2017, p.598

NewsRX LLC

Texto completo disponível

Citações Citado por
7
Vanda Presents Phase III Iloperidone Efficacy Data
Vanda Presents Phase III Iloperidone Efficacy Data
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

Vanda Presents Phase III Iloperidone Efficacy Data

Science Letter, 2007, p.4332-4332

NewsRX LLC

Texto completo disponível

Citações Citado por
8
Vanda Presents Phase III Iloperidone Efficacy Data
Vanda Presents Phase III Iloperidone Efficacy Data
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

Vanda Presents Phase III Iloperidone Efficacy Data

Health & Medicine Week, 2007, p.3725

NewsRX LLC

Texto completo disponível

Citações Citado por
9
Rigrodsky Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Vanda Pharmaceuticals Inc
Rigrodsky Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Vanda Pharmaceuticals Inc
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

Rigrodsky Long, P.A. Announces A Securities Fraud Class Action Lawsuit Has Been Filed Against Vanda Pharmaceuticals Inc

Clinical Trials Week, 2013, p.398

NewsRX LLC

Texto completo disponível

Citações Citado por
10
FDA Approves Vanda Pharmaceuticals' Fanapt for the Treatment of Schizophrenia
FDA Approves Vanda Pharmaceuticals' Fanapt for the Treatment of Schizophrenia
Material Type:
Newsletter Articles 		Adicionar ao Meu Espaço

FDA Approves Vanda Pharmaceuticals' Fanapt for the Treatment of Schizophrenia

Biotech Week, 2009, p.3715

NewsRX LLC

Texto completo disponível

Citações Citado por
Resultados 1 2 3 4 5 next page

Personalize Seus Resultados

  1. Editar

Refine Search Results

Expandir Meus Resultados

  1.   

Data de Publicação 

De até
Refinar
  1. Antes de2007  (26)
  2. 2007Até2012  (6)
  3. 2013Até2015  (40)
  4. 2016Até2019  (29)
  5. Após 2019  (71)
  6. Mais opções open sub menu

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.